Fluid matters in choosing antihypertensive therapy: a hypothesis that the data speak volumes

Robert P Blankfield1

  • 1Department of Family Medicine, Case Western Reserve University, School of Medicine, Cleveland, OH, USA. blankfield@adelphia.net

Insights

Diuretics are the most effective antihypertensive drugs for preventing heart failure and strokes, followed by ACE inhibitors and ARBs. Beta-blockers are third-tier, while CCBs and alpha-blockers are least preferred due to fluid retention.

Area of Science:

  • Cardiology
  • Pharmacology
  • Hypertension Management

Background:

  • Antihypertensive medications vary in their effectiveness for preventing cardiovascular diseases.
  • A conceptual framework is lacking to organize these differences.
  • Fluid balance is a key factor influencing cardiovascular outcomes.

Purpose of the Study:

  • To propose a framework for ranking antihypertensive medications based on their effects on fluid balance.
  • To evaluate the efficacy of different drug classes in preventing cardiovascular events.

Main Methods:

  • Comparative analysis of antihypertensive drug classes.
  • Assessment of fluid reduction versus fluid retention properties.
  • Review of cardiovascular event prevention data.

Main Results:

  • Diuretics are superior to ACE inhibitors, CCBs, and alpha-blockers in preventing heart failure.
  • Diuretics are more effective than ACE inhibitors and alpha-blockers in preventing strokes.
  • CCBs are less effective than beta-blockers and ACE inhibitors in reducing myocardial infarcts and heart failure.
  • ACE inhibitors and ARBs promote fluid reduction, ranking second to diuretics.
  • Beta-blockers have a neutral effect on fluid balance, ranking third.
  • CCBs and alpha-blockers promote fluid retention, making them least preferred.

Conclusions:

  • Fluid reduction is a critical factor in ranking antihypertensive medications.
  • Diuretics are the preferred first-line treatment for hypertension due to their fluid-reducing properties.
  • Medications promoting fluid retention, like CCBs and alpha-blockers, should be used cautiously.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...